USD10
PALI Shares
About Palisade BioPalisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
USD10
PALI Shares
About Palisade BioPalisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$336.45M
OPEN PRICE
$2.10
LOW (1Y)
$0.53
HIGH (1Y)
$2.86
LOW (24H)
$1.92
HIGH (24H)
$2.15
VOLUME (24H)
$2.11M
38.45%
Price history
Time | Price | Change |
|---|---|---|
Today | $2.10 | |
1 Day | $1.99 | |
1 Week | $2.07 | |
1 Month | $1.69 | |
1 Year | $0.78 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Popular cryptocurrencies
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.